Eliem Therapeutics

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.

Investing News NetworkYour trusted source for investing success

Reducing Reliance on China for Rare Earths Production and Processing

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Top 5 Canadian Uranium Stocks of 2024

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

A State-by-State Guide to Cannabis in Australia (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Top 10 Copper-producing Companies (Updated 2024)

11 Canadian Crypto ETFs (Updated 2024)

New High-Grade 35% Copper and 10g/t Gold Rock Chips at Ti-Tree

RecycLiCo Taiwan Battery Recycling Joint Venture Commences Production and Sales of Black Powder

Drill Results Extend Mineralisation at Lana Corina to 454m @ 0.93% CuEq

Skyharbour Drills New Discovery at Russell Project with High-Grade Uranium Mineralization Up to 3.0% U3O8 at Newly Identified Fork Zone; Preparing for Fully-Funded Summer Drill Program

Rua Gold to Acquire Siren Gold's Reefton Assets and Become the Dominant Reefton Goldfield Explorer

Purepoint Uranium Provides Exploration Update on Geophysical Programs at Russell South, Tabbernor, and Smart Lake Projects

Ora Gold Limited

Alvopetro Energy

Tempest Minerals

Galan Lithium

2024 Lithium Market Outlook (Updated for Q2)

2024 Gold Outlook Report

2024 Copper Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

Eliem Therapeutics

Top 5 NASDAQ Biotech Stocks

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2023

Interactive Chart